Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
Abstract
1. Introduction
1.1. Ebola Virus
1.2. Extracellular Vesicles
2. EVs and VP40
2.1. VP40 and the ESCRT Pathway
2.2. VP40 Influence on the Host Cell Cycle
2.3. EV-Associated VP40 and Recipient Bystander Cell Effects
3. EVs and NP
4. EVs and GP
5. Remaining Questions
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Disclaimer
References
- WHO. Ebola Outbreak 2014–2015. Available online: http://www.who.int/csr/disease/ebola/en/ (accessed on 7 January 2019).
- Ebola. Ebola Situation Reports: Democratic Republic of the Congo. Available online: http://www.who.int/ebola/situation-reports/drc-2018/en/ (accessed on 7 January 2019).
- WHO. Ebola Virus Disease—Democratic Republic of the Congo. Available online: http://www.who.int/csr/don/25-july-2018-ebola-drc/en/ (accessed on 1 August 2018).
- Rougeron, V.; Feldmann, H.; Grard, G.; Becker, S.; Leroy, E.M. Ebola and Marburg haemorrhagic fever. J. Clin. Virol. 2015, 64, 111–119. [Google Scholar] [CrossRef] [PubMed]
- MüHlberger, E. Filovirus replication and transcription. Future Virol. 2007, 2, 205–215. [Google Scholar] [CrossRef] [PubMed]
- Sanchez, A.; Kiley, M.P.; Holloway, B.P.; Auperin, D.D. Sequence analysis of the Ebola virus genome: Organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 1993, 29, 215–240. [Google Scholar] [CrossRef]
- Volchkov, V.E.; Becker, S.; Volchkova, V.A.; Ternovoj, V.A.; Kotov, A.N.; Netesov, S.V.; Klenk, H.-D. GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases1. Virology 1995, 214, 421–430. [Google Scholar] [CrossRef]
- Sanchez, A.; Trappier, S.G.; Mahy, B.W.; Peters, C.J.; Nichol, S.T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA 1996, 93, 3602–3607. [Google Scholar] [CrossRef]
- Manicassamy, B.; Wang, J.; Rumschlag, E.; Tymen, S.; Volchkova, V.; Volchkov, V.; Rong, L. Characterization of Marburg virus glycoprotein in viral entry. Virology 2007, 358, 79–88. [Google Scholar] [CrossRef] [PubMed]
- Cook, J.D.; Lee, J.E. The Secret Life of Viral Entry Glycoproteins: Moonlighting in Immune Evasion. PLoS Pathog. 2013, 9, e1003258. [Google Scholar] [CrossRef] [PubMed]
- Geisbert, T.W.; Hensley, L.E.; Larsen, T.; Young, H.A.; Reed, D.S.; Geisbert, J.B.; Scott, D.P.; Kagan, E.; Jahrling, P.B.; Davis, K.J. Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques: Evidence that Dendritic Cells Are Early and Sustained Targets of Infection. Am. J. Pathol. 2003, 163, 2347–2370. [Google Scholar] [CrossRef]
- Ryabchikova, E.I.; Kolesnikova, L.V.; Luchko, S.V. An Analysis of Features of Pathogenesis in Two Animal Models of Ebola Virus Infection. J. Infect. Dis. 1999, 179, S199–S202. [Google Scholar] [CrossRef]
- Martines, R.B.; Ng, D.L.; Greer, P.W.; Rollin, P.E.; Zaki, S.R. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J. Pathol. 2015, 235, 153–174. [Google Scholar] [CrossRef] [PubMed]
- Messaoudi, I.; Amarasinghe, G.K.; Basler, C.F. Filovirus pathogenesis and immune evasion: Insights from Ebola virus and Marburg virus. Nat. Rev. Microbiol. 2015, 13, 663–676. [Google Scholar] [CrossRef] [PubMed]
- Falasca, L.; Agrati, C.; Petrosillo, N.; Di Caro, A.; Capobianchi, M.R.; Ippolito, G.; Piacentini, M. Molecular mechanisms of Ebola virus pathogenesis: Focus on cell death. Cell Death Differ. 2015, 22, 1250–1259. [Google Scholar] [CrossRef] [PubMed]
- Zaki, S.R.; Goldsmith, C.S. Pathologic features of filovirus infections in humans. Curr. Top. Microbiol. Immunol. 1999, 235, 97–116. [Google Scholar]
- Deen, G.F.; Broutet, N.; Xu, W.; Knust, B.; Sesay, F.R.; McDonald, S.L.R.; Ervin, E.; Marrinan, J.E.; Gaillard, P.; Habib, N.; et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report. N. Engl. J. Med. 2017, 377, 1428–1437. [Google Scholar] [CrossRef]
- Varkey, J.B.; Shantha, J.G.; Crozier, I.; Kraft, C.S.; Lyon, G.M.; Mehta, A.K.; Kumar, G.; Smith, J.R.; Kainulainen, M.H.; Whitmer, S.; et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N. Engl. J. Med. 2015, 372, 2423–2427. [Google Scholar] [CrossRef]
- Sissoko, D.; Keïta, M.; Diallo, B.; Aliabadi, N.; Fitter, D.L.; Dahl, B.A.; Bore, J.A.; Koundouno, F.R.; Singethan, K.; Meisel, S.; et al. Ebola virus persistence in breast milk after no reported illness: A likely source of virus transmission from mother to child. Clin. Infect. Dis. 2017, 64, 513–516. [Google Scholar] [CrossRef]
- Vetter, P.; Fischer, W.A.; Schibler, M.; Jacobs, M.; Bausch, D.G.; Kaiser, L. Ebola Virus Shedding and Transmission: Review of Current Evidence. J. Infect. Dis. 2016, 214, S177–S184. [Google Scholar] [CrossRef]
- Mora-Rillo, M.; Arsuaga, M.; Ramírez-Olivencia, G.; de la Calle, F.; Borobia, A.M.; Sánchez-Seco, P.; Lago, M.; Figueira, J.C.; Fernández-Puntero, B.; Viejo, A.; et al. Acute respiratory distress syndrome after convalescent plasma use: Treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir. Med. 2015, 3, 554–562. [Google Scholar] [CrossRef]
- Liddell, A.M.; Davey, R.T.; Mehta, A.K.; Varkey, J.B.; Kraft, C.S.; Tseggay, G.K.; Badidi, O.; Faust, A.C.; Brown, K.V.; Suffredini, A.F.; et al. Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann. Intern. Med. 2015, 163, 81–90. [Google Scholar] [CrossRef]
- Nordenstedt, H.; Bah, E.I.; de la Vega, M.-A.; Barry, M.; N’Faly, M.; Barry, M.; Crahay, B.; Decroo, T.; Van Herp, M.; Ingelbeen, B. Ebola Virus in Breast Milk in an Ebola Virus–Positive Mother with Twin Babies, Guinea, 2015. Emerg. Infect. Dis. 2016, 22, 759–760. [Google Scholar] [CrossRef]
- Brainard, J.; Pond, K.; Hooper, L.; Edmunds, K.; Hunter, P. Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review. PLoS Negl. Trop. Dis. 2016, 10, e0004475. [Google Scholar] [CrossRef]
- MacIntyre, C.R.; Chughtai, A.A. Recurrence and reinfection—a new paradigm for the management of Ebola virus disease. Int. J. Infect. Dis. 2016, 43, 58–61. [Google Scholar] [CrossRef]
- Overholt, L.; Wohl, D.A.; Fischer, W.A.; Westreich, D.; Tozay, S.; Reeves, E.; Pewu, K.; Adjasso, D.; Hoover, D.; Merenbloom, C.; et al. Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study. PLoS ONE 2018, 13, e0206595. [Google Scholar] [CrossRef]
- Chan, J.; Patel, M.; Tobin, S.; Sheppeard, V. Monitoring travellers from Ebola-affected countries in New South Wales, Australia: What is the impact on travellers? BMC Public Health 2017, 17, 113. [Google Scholar] [CrossRef]
- Van Bortel, T.; Basnayake, A.; Wurie, F.; Jambai, M.; Koroma, A.S.; Muana, A.T.; Hann, K.; Eaton, J.; Martin, S.; Nellums, L.B. Psychosocial effects of an Ebola outbreak at individual, community and international levels. Bull. World Health Organ. 2016, 94, 210–214. [Google Scholar] [CrossRef]
- Davtyan, M.; Brown, B.; Folayan, M.O. Addressing Ebola-related Stigma: Lessons Learned from HIV/AIDS. Glob. Health Action 2014, 7, 26058. [Google Scholar] [CrossRef]
- Mate, S.E.; Kugelman, J.R.; Nyenswah, T.G.; Ladner, J.T.; Wiley, M.R.; Cordier-Lassalle, T.; Christie, A.; Schroth, G.P.; Gross, S.M.; Davies-Wayne, G.J.; et al. Molecular Evidence of Sexual Transmission of Ebola Virus. N. Engl. J. Med. 2015, 373, 2448–2454. [Google Scholar] [CrossRef]
- Christie, A.; Davies-Wayne, G.J.; Cordier-Lassalle, T.; Cordier-Lasalle, T.; Blackley, D.J.; Laney, A.S.; Williams, D.E.; Shinde, S.A.; Badio, M.; Lo, T.; et al. Possible sexual transmission of Ebola virus-Liberia, 2015. MMWR Morb. Mortal. Wkly. Rep. 2015, 64, 479–481. [Google Scholar]
- Subissi, L.; Keita, M.; Mesfin, S.; Rezza, G.; Diallo, B.; Van Gucht, S.; Musa, E.O.; Yoti, Z.; Keita, S.; Djingarey, M.H.; et al. Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014–2016 Outbreak in West Africa. J. Infect. Dis. 2018, 218, S287–S291. [Google Scholar] [CrossRef]
- Arias, A.; Watson, S.J.; Asogun, D.; Tobin, E.A.; Lu, J.; Phan, M.V.T.; Jah, U.; Wadoum, R.E.G.; Meredith, L.; Thorne, L.; et al. Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases. Virus Evol. 2016, 2, vew016. [Google Scholar] [CrossRef]
- Keita, M.; Duraffour, S.; Loman, N.J.; Rambaut, A.; Diallo, B.; Magassouba, N.; Carroll, M.W.; Quick, J.; Sall, A.A.; Glynn, J.R.; et al. Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014–2015. Emerg. Infect. Dis. 2016, 22, 2149–2152. [Google Scholar] [CrossRef] [PubMed]
- Diallo, B.; Sissoko, D.; Loman, N.J.; Bah, H.A.; Bah, H.; Worrell, M.C.; Conde, L.S.; Sacko, R.; Mesfin, S.; Loua, A.; et al. Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clin. Infect. Dis. 2016, 63, 1353–1356. [Google Scholar] [CrossRef] [PubMed]
- Leroy, E.; Baize, S.; Volchkov, V.; Fisher-Hoch, S.; Georges-Courbot, M.-C.; Lansoud-Soukate, J.; Capron, M.; Debré, P.; Georges, A.; McCormick, J. Human asymptomatic Ebola infection and strong inflammatory response. The Lancet 2000, 355, 2210–2215. [Google Scholar] [CrossRef]
- Mbala, P.; Baguelin, M.; Ngay, I.; Rosello, A.; Mulembakani, P.; Demiris, N.; Edmunds, W.J.; Muyembe, J.-J. Evaluating the frequency of asymptomatic Ebola virus infection. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2017, 372. [Google Scholar] [CrossRef] [PubMed]
- Glynn, J.R.; Bower, H.; Johnson, S.; Houlihan, C.F.; Montesano, C.; Scott, J.T.; Semple, M.G.; Bangura, M.S.; Kamara, A.J.; Kamara, O.; et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: A cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect. Dis. 2017, 17, 645–653. [Google Scholar] [CrossRef]
- Dean, N.E.; Halloran, M.E.; Yang, Y.; Longini, I.M. Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2016, 62, 1277–1286. [Google Scholar] [CrossRef] [PubMed]
- Richardson, E.T.; Kelly, J.D.; Barrie, M.B.; Mesman, A.W.; Karku, S.; Quiwa, K.; Marsh, R.H.; Koedoyoma, S.; Daboh, F.; Barron, K.P.; et al. Minimally Symptomatic Infection in an Ebola ‘Hotspot’: A Cross-Sectional Serosurvey. PLoS Negl. Trop. Dis. 2016, 10, e0005087. [Google Scholar] [CrossRef]
- Clark, D.V.; Kibuuka, H.; Millard, M.; Wakabi, S.; Lukwago, L.; Taylor, A.; Eller, M.A.; Eller, L.A.; Michael, N.L.; Honko, A.N.; et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study. Lancet Infect. Dis. 2015, 15, 905–912. [Google Scholar] [CrossRef]
- Rowe, A.K.; Bertolli, J.; Khan, A.S.; Mukunu, R.; Muyembe-Tamfum, J.J.; Bressler, D.; Williams, A.J.; Peters, C.J.; Rodriguez, L.; Feldmann, H.; et al. Clinical, Virologic, and Immunologic Follow-Up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of the Congo. J. Infect. Dis. 1999, 179, S28–S35. [Google Scholar] [CrossRef]
- Bower, H.; Glynn, J.R. A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. Sci. Data 2017, 4, 160133. [Google Scholar] [CrossRef][Green Version]
- Houlihan, C.F.; McGowan, C.R.; Dicks, S.; Baguelin, M.; Moore, D.A.J.; Mabey, D.; Roberts, C.H.; Kumar, A.; Samuel, D.; Tedder, R.; et al. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014–2016: A cross-sectional study. PLoS Med. 2017, 14, e1002300. [Google Scholar] [CrossRef] [PubMed]
- Raposo, G.; Stoorvogel, W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200, 373–383. [Google Scholar] [CrossRef]
- Colombo, M.; Raposo, G.; Théry, C. Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annu. Rev. Cell Dev. Biol. 2014, 30, 255–289. [Google Scholar] [CrossRef]
- Abels, E.R.; Breakefield, X.O. Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake. Cell Mol. Neurobiol. 2016, 36, 301–312. [Google Scholar] [CrossRef]
- Xu, R.; Greening, D.W.; Zhu, H.-J.; Takahashi, N.; Simpson, R.J. Extracellular vesicle isolation and characterization: Toward clinical application. J. Clin. Invest. 2016, 126, 1152–1162. [Google Scholar] [CrossRef]
- Akers, J.C.; Gonda, D.; Kim, R.; Carter, B.S.; Chen, C.C. Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J. Neurooncol. 2013, 113, 1–11. [Google Scholar] [CrossRef]
- Keller, S.; Sanderson, M.P.; Stoeck, A.; Altevogt, P. Exosomes: From biogenesis and secretion to biological function. Immunol. Lett. 2006, 107, 102–108. [Google Scholar] [CrossRef]
- Schmidt, O.; Teis, D. The ESCRT machinery. Curr. Biol. 2012, 22, R116–R120. [Google Scholar] [CrossRef]
- Henne, W.M.; Buchkovich, N.J.; Emr, S.D. The ESCRT Pathway. Dev. Cell 2011, 21, 77–91. [Google Scholar] [CrossRef] [PubMed]
- Stuffers, S.; Sem Wegner, C.; Stenmark, H.; Brech, A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic Cph. Den. 2009, 10, 925–937. [Google Scholar] [CrossRef]
- van Niel, G.; Charrin, S.; Simoes, S.; Romao, M.; Rochin, L.; Saftig, P.; Marks, M.S.; Rubinstein, E.; Raposo, G. The Tetraspanin CD63 Regulates ESCRT-Independent and -Dependent Endosomal Sorting during Melanogenesis. Dev. Cell 2011, 21, 708–721. [Google Scholar] [CrossRef]
- Edgar, J.R.; Eden, E.R.; Futter, C.E. Hrs- and CD63-Dependent Competing Mechanisms Make Different Sized Endosomal Intraluminal Vesicles. Traffic 2014, 15, 197–211. [Google Scholar] [CrossRef]
- Ghossoub, R.; Lembo, F.; Rubio, A.; Gaillard, C.B.; Bouchet, J.; Vitale, N.; Slavík, J.; Machala, M.; Zimmermann, P. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat. Commun. 2014, 5, 3477. [Google Scholar] [CrossRef]
- Trajkovic, K.; Hsu, C.; Chiantia, S.; Rajendran, L.; Wenzel, D.; Wieland, F.; Schwille, P.; Brügger, B.; Simons, M. Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes. Science 2008, 319, 1244–1247. [Google Scholar] [CrossRef]
- Alenquer, M.; Amorim, M.J. Exosome Biogenesis, Regulation, and Function in Viral Infection. Viruses 2015, 7, 5066–5083. [Google Scholar] [CrossRef]
- Vitelli, R.; Santillo, M.; Lattero, D.; Chiariello, M.; Bifulco, M.; Bruni, C.B.; Bucci, C. Role of the Small GTPase RAB7 in the Late Endocytic Pathway. J. Biol. Chem. 1997, 272, 4391–4397. [Google Scholar] [CrossRef]
- Feng, Y.; Press, B.; Wandinger-Ness, A. Rab 7: An important regulator of late endocytic membrane traffic. J. Cell Biol. 1995, 131, 1435–1452. [Google Scholar] [CrossRef]
- Baietti, M.F.; Zhang, Z.; Mortier, E.; Melchior, A.; Degeest, G.; Geeraerts, A.; Ivarsson, Y.; Depoortere, F.; Coomans, C.; Vermeiren, E.; et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 2012, 14, 677–685. [Google Scholar] [CrossRef]
- Ostrowski, M.; Carmo, N.B.; Krumeich, S.; Fanget, I.; Raposo, G.; Savina, A.; Moita, C.F.; Schauer, K.; Hume, A.N.; Freitas, R.P.; et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010, 12, 19–30. [Google Scholar] [CrossRef]
- Savina, A.; Vidal, M.; Colombo, M.I. The exosome pathway in K562 cells is regulated by Rab11. J. Cell Sci. 2002, 115, 2505–2515. [Google Scholar]
- Beckett, K.; Monier, S.; Palmer, L.; Alexandre, C.; Green, H.; Bonneil, E.; Raposo, G.; Thibault, P.; Le Borgne, R.; Vincent, J.-P. Drosophila S2 cells secrete wingless on exosome-like vesicles but the wingless gradient forms independently of exosomes. Traffic Cph. Den. 2013, 14, 82–96. [Google Scholar] [CrossRef]
- Abrami, L.; Brandi, L.; Moayeri, M.; Brown, M.J.; Krantz, B.A.; Leppla, S.H.; van der Goot, F.G. Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin. Cell Rep. 2013, 5, 986–996. [Google Scholar] [CrossRef]
- Koles, K.; Budnik, V. Exosomes go with the Wnt. Cell. Logist. 2012, 2, 169–173. [Google Scholar] [CrossRef]
- Hsu, C.; Morohashi, Y.; Yoshimura, S.-I.; Manrique-Hoyos, N.; Jung, S.; Lauterbach, M.A.; Bakhti, M.; Grønborg, M.; Möbius, W.; Rhee, J.; et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 2010, 189, 223–232. [Google Scholar] [CrossRef]
- Peinado, H.; Alečković, M.; Lavotshkin, S.; Matei, I.; Costa-Silva, B.; Moreno-Bueno, G.; Hergueta-Redondo, M.; Williams, C.; García-Santos, G.; Ghajar, C.; et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 2012, 18, 883–891. [Google Scholar] [CrossRef]
- Bobrie, A.; Krumeich, S.; Reyal, F.; Recchi, C.; Moita, L.F.; Seabra, M.C.; Ostrowski, M.; Théry, C. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012, 72, 4920–4930. [Google Scholar] [CrossRef]
- Anderson, M.R.; Kashanchi, F.; Jacobson, S. Exosomes in Viral Disease. Neurother. J. Am. Soc. Exp. Neurother. 2016, 13, 535–546. [Google Scholar] [CrossRef]
- Schwab, A.; Meyering, S.S.; Lepene, B.; Iordanskiy, S.; van Hoek, M.L.; Hakami, R.M.; Kashanchi, F. Extracellular vesicles from infected cells: Potential for direct pathogenesis. Front. Microbiol. 2015, 6, 1132. [Google Scholar] [CrossRef]
- Crenshaw, B.J.; Gu, L.; Sims, B.; Matthews, Q.L. Exosome Biogenesis and Biological Function in Response to Viral Infections. Open Virol. J. 2018, 12, 134–148. [Google Scholar] [CrossRef]
- Votteler, J.; Sundquist, W.I. Virus Budding and the ESCRT Pathway. Cell Host Microbe 2013, 14, 232–241. [Google Scholar] [CrossRef]
- Ahmed, I.; Akram, Z.; Iqbal, H.M.N.; Munn, A.L. The regulation of Endosomal Sorting Complex Required for Transport and accessory proteins in multivesicular body sorting and enveloped viral budding-An overview. Int. J. Biol. Macromol. 2019, 127, 1–11. [Google Scholar] [CrossRef]
- Christ, L.; Raiborg, C.; Wenzel, E.M.; Campsteijn, C.; Stenmark, H. Cellular Functions and Molecular Mechanisms of the ESCRT Membrane-Scission Machinery. Trends Biochem. Sci. 2017, 42, 42–56. [Google Scholar] [CrossRef]
- Han, Z.; Madara, J.J.; Liu, Y.; Liu, W.; Ruthel, G.; Freedman, B.D.; Harty, R.N. ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress. J. Infect. Dis. 2015, 212 Suppl 2, S138–S145. [Google Scholar] [CrossRef]
- Licata, J.M.; Simpson-Holley, M.; Wright, N.T.; Han, Z.; Paragas, J.; Harty, R.N. Overlapping Motifs (PTAP and PPEY) within the Ebola Virus VP40 Protein Function Independently as Late Budding Domains: Involvement of Host Proteins TSG101 and VPS-4. J. Virol. 2003, 77, 1812–1819. [Google Scholar] [CrossRef]
- Martin-Serrano, J.; Zang, T.; Bieniasz, P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 2001, 7, 1313–1319. [Google Scholar] [CrossRef]
- Garrus, J.E.; von Schwedler, U.K.; Pornillos, O.W.; Morham, S.G.; Zavitz, K.H.; Wang, H.E.; Wettstein, D.A.; Stray, K.M.; Côté, M.; Rich, R.L.; et al. Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding. Cell 2001, 107, 55–65. [Google Scholar] [CrossRef]
- Ku, P.-I.; Bendjennat, M.; Ballew, J.; Landesman, M.B.; Saffarian, S. ALIX Is Recruited Temporarily into HIV-1 Budding Sites at the End of Gag Assembly. PLoS ONE 2014, 9, e96950. [Google Scholar] [CrossRef]
- Carlton, J.G.; Agromayor, M.; Martin-Serrano, J. Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. Proc. Natl. Acad. Sci. USA 2008, 105, 10541–10546. [Google Scholar] [CrossRef]
- Strack, B.; Calistri, A.; Craig, S.; Popova, E.; Göttlinger, H.G. AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding. Cell 2003, 114, 689–699. [Google Scholar] [CrossRef]
- Silvestri, L.S.; Ruthel, G.; Kallstrom, G.; Warfield, K.L.; Swenson, D.L.; Nelle, T.; Iversen, P.L.; Bavari, S.; Aman, M.J. Involvement of Vacuolar Protein Sorting Pathway in Ebola Virus Release Independent of TSG101 Interaction. J. Infect. Dis. 2007, 196, S264–S270. [Google Scholar] [CrossRef]
- Goff, A.; Ehrlich, L.S.; Cohen, S.N.; Carter, C.A. Tsg101 Control of Human Immunodeficiency Virus Type 1 Gag Trafficking and Release. J. Virol. 2003, 77, 9173–9182. [Google Scholar] [CrossRef] [PubMed]
- Dussupt, V.; Javid, M.P.; Abou-Jaoudé, G.; Jadwin, J.A.; Cruz, J. de L.; Nagashima, K.; Bouamr, F. The Nucleocapsid Region of HIV-1 Gag Cooperates with the PTAP and LYPXnL Late Domains to Recruit the Cellular Machinery Necessary for Viral Budding. PLoS Pathog. 2009, 5, e1000339. [Google Scholar] [CrossRef] [PubMed]
- Greening, D.W.; Xu, R.; Ji, H.; Tauro, B.J.; Simpson, R.J. A protocol for exosome isolation and characterization: Evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol. Biol. Clifton NJ 2015, 1295, 179–209. [Google Scholar]
- Konoshenko, M.Y.; Lekchnov, E.A.; Vlassov, A.V.; Laktionov, P.P. Isolation of Extracellular Vesicles: General Methodologies and Latest Trends. BioMed Res. Int. 2018, 2018, 8545347. [Google Scholar] [CrossRef]
- Taylor, D.D.; Shah, S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods 2015, 87, 3–10. [Google Scholar] [CrossRef]
- Momen-Heravi, F.; Balaj, L.; Alian, S.; Mantel, P.-Y.; Halleck, A.E.; Trachtenberg, A.J.; Soria, C.E.; Oquin, S.; Bonebreak, C.M.; Saracoglu, E.; et al. Current methods for the isolation of extracellular vesicles. Biol. Chem. 2013, 394, 1253–1262. [Google Scholar] [CrossRef] [PubMed]
- DeMarino, C.; Pleet, M.L.; Cowen, M.; Barclay, R.A.; Akpamagbo, Y.; Erickson, J.; Ndembe, N.; Charurat, M.; Jumare, J.; Bwala, S.; et al. Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells. Sci. Rep. 2018, 8, 7653. [Google Scholar] [CrossRef] [PubMed]
- Timmins, J.; Scianimanico, S.; Schoehn, G.; Weissenhorn, W. Vesicular Release of Ebola Virus Matrix Protein VP40. Virology 2001, 283, 1–6. [Google Scholar] [CrossRef]
- Kallstrom, G.; Warfield, K.L.; Swenson, D.L.; Mort, S.; Panchal, R.G.; Ruthel, G.; Bavari, S.; Aman, M.J. Analysis of Ebola virus and VLP release using an immunocapture assay. J. Virol. Methods 2005, 127, 1–9. [Google Scholar] [CrossRef]
- Bavari, S.; Bosio, C.M.; Wiegand, E.; Ruthel, G.; Will, A.B.; Geisbert, T.W.; Hevey, M.; Schmaljohn, C.; Schmaljohn, A.; Aman, M.J. Lipid Raft Microdomains: A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses. J. Exp. Med. 2002, 195, 593–602. [Google Scholar] [CrossRef]
- Beniac, D.R.; Melito, P.L.; deVarennes, S.L.; Hiebert, S.L.; Rabb, M.J.; Lamboo, L.L.; Jones, S.M.; Booth, T.F. The Organisation of Ebola Virus Reveals a Capacity for Extensive, Modular Polyploidy. PLoS ONE 2012, 7, e29608. [Google Scholar] [CrossRef]
- Pleet, M.L.; Mathiesen, A.; DeMarino, C.; Akpamagbo, Y.A.; Barclay, R.A.; Schwab, A.; Iordanskiy, S.; Sampey, G.C.; Lepene, B.; Nekhai, S.; et al. Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction. Front. Microbiol. 2016, 7, 1765. [Google Scholar] [CrossRef]
- Pleet, M.L.; Erickson, J.; DeMarino, C.; Barclay, R.A.; Cowen, M.; Lepene, B.; Liang, J.; Kuhn, J.H.; Prugar, L.I.; Stonier, S.W.; et al. Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Veiscles. J Infect Dis. 2018, 218, S365–S387. [Google Scholar] [CrossRef]
- Cantin, R.; Diou, J.; Bélanger, D.; Tremblay, A.M.; Gilbert, C. Discrimination between exosomes and HIV-1: Purification of both vesicles from cell-free supernatants. J. Immunol. Methods 2008, 338, 21–30. [Google Scholar] [CrossRef]
- Pleet, M.L.; DeMarino, C.; Lepene, B.; Aman, M.J.; Kashanchi, F. The Role of Exosomal VP40 in Ebola Virus Disease. DNA Cell Biol. 2017, 36, 243–248. [Google Scholar] [CrossRef]
- Timmins, J.; Schoehn, G.; Ricard-Blum, S.; Scianimanico, S.; Vernet, T.; Ruigrok, R.W.H.; Weissenhorn, W. Ebola Virus Matrix Protein VP40 Interaction with Human Cellular Factors Tsg101 and Nedd4. J. Mol. Biol. 2003, 326, 493–502. [Google Scholar] [CrossRef]
- Hartlieb, B.; Weissenhorn, W. Filovirus assembly and budding. Virology 2006, 344, 64–70. [Google Scholar] [CrossRef]
- Jasenosky, L.D.; Neumann, G.; Lukashevich, I.; Kawaoka, Y. Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer. J. Virol. 2001, 75, 5205–5214. [Google Scholar] [CrossRef]
- Noda, T.; Sagara, H.; Suzuki, E.; Takada, A.; Kida, H.; Kawaoka, Y. Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP. J. Virol. 2002, 76, 4855–4865. [Google Scholar] [CrossRef]
- Licata, J.M.; Johnson, R.F.; Han, Z.; Harty, R.N. Contribution of Ebola Virus Glycoprotein, Nucleoprotein, and VP24 to Budding of VP40 Virus-Like Particles. J. Virol. 2004, 78, 7344–7351. [Google Scholar] [CrossRef]
- Noda, T.; Ebihara, H.; Muramoto, Y.; Fujii, K.; Takada, A.; Sagara, H.; Kim, J.H.; Kida, H.; Feldmann, H.; Kawaoka, Y. Assembly and Budding of Ebolavirus. PLoS Pathog. 2006, 2, e99. [Google Scholar] [CrossRef]
- Surjit, M.; Oberoi, R.; Kumar, R.; Lal, S.K. Enhanced α1 Microglobulin Secretion from Hepatitis E Virus ORF3-expressing Human Hepatoma Cells Is Mediated by the Tumor Susceptibility Gene 101. J. Biol. Chem. 2006, 281, 8135–8142. [Google Scholar] [CrossRef]
- Nagashima, S.; Takahashi, M.; Jirintai, S.; Tanaka, T.; Nishizawa, T.; Yasuda, J.; Okamoto, H. Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J. Gen. Virol. 2011, 92, 2838–2848. [Google Scholar] [CrossRef]
- Park, A.; Yun, T.; Vigant, F.; Pernet, O.; Won, S.T.; Dawes, B.E.; Bartkowski, W.; Freiberg, A.N.; Lee, B. Nipah Virus C Protein Recruits Tsg101 to Promote the Efficient Release of Virus in an ESCRT-Dependent Pathway. PLoS Pathog. 2016, 12, e1005659. [Google Scholar] [CrossRef]
- Bissig, C.; Gruenberg, J. ALIX and the multivesicular endosome: ALIX in Wonderland. Trends Cell Biol. 2014, 24, 19–25. [Google Scholar] [CrossRef]
- Zhai, Q.; Fisher, R.D.; Chung, H.-Y.; Myszka, D.G.; Sundquist, W.I.; Hill, C.P. Structural and functional studies of ALIX interactions with YPXnL late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 2008, 15, 43–49. [Google Scholar] [CrossRef]
- Yasuda, J.; Nakao, M.; Kawaoka, Y.; Shida, H. Nedd4 Regulates Egress of Ebola Virus-Like Particles from Host Cells. J. Virol. 2003, 77, 9987–9992. [Google Scholar] [CrossRef]
- Malakhova, O.A.; Zhang, D.-E. ISG15 Inhibits Nedd4 Ubiquitin E3 Activity and Enhances the Innate Antiviral Response. J. Biol. Chem. 2008, 283, 8783–8787. [Google Scholar] [CrossRef]
- Han, Z.; Sagum, C.A.; Bedford, M.T.; Sidhu, S.S.; Sudol, M.; Harty, R.N. ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding. J. Virol. 2016, 90, 9163–9171. [Google Scholar] [CrossRef]
- Han, Z.; Sagum, C.A.; Takizawa, F.; Ruthel, G.; Berry, C.T.; Kong, J.; Sunyer, J.O.; Freedman, B.D.; Bedford, M.T.; Sidhu, S.S.; et al. Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress. J. Virol. 2017, 91, e00812-17. [Google Scholar] [CrossRef]
- Okumura, A.; Rasmussen, A.L.; Halfmann, P.; Feldmann, F.; Yoshimura, A.; Feldmann, H.; Kawaoka, Y.; Harty, R.N.; Katze, M.G. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection. J. Virol. 2015, 89, 10399–10406. [Google Scholar] [CrossRef]
- Nascimento, R.; Costa, H.; Parkhouse, R.M.E. Virus manipulation of cell cycle. Protoplasma 2012, 249, 519–528. [Google Scholar] [CrossRef]
- Fehr, A.R.; Yu, D. Control the Host Cell Cycle: Viral Regulation of the Anaphase-Promoting Complex. J. Virol. 2013, 87, 8818–8825. [Google Scholar] [CrossRef]
- Dove, B.; Brooks, G.; Bicknell, K.; Wurm, T.; Hiscox, J.A. Cell Cycle Perturbations Induced by Infection with the Coronavirus Infectious Bronchitis Virus and Their Effect on Virus Replication. J. Virol. 2006, 80, 4147–4156. [Google Scholar] [CrossRef]
- Chaurushiya, M.S.; Weitzman, M.D. Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair 2009, 8, 1166–1176. [Google Scholar] [CrossRef]
- Santiago, F.; Clark, E.; Chong, S.; Molina, C.; Mozafari, F.; Mahieux, R.; Fujii, M.; Azimi, N.; Kashanchi, F. Transcriptional Up-Regulation of the Cyclin D2 Gene and Acquisition of New Cyclin-Dependent Kinase Partners in Human T-Cell Leukemia Virus Type 1-Infected Cells. J. Virol. 1999, 73, 9917–9927. [Google Scholar]
- Kehn, K.; Deng, L.; de la Fuente, C.; Strouss, K.; Wu, K.; Maddukuri, A.; Baylor, S.; Rufner, R.; Pumfery, A.; Bottazzi, M.E.; et al. The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology 2004, 1, 6. [Google Scholar] [CrossRef][Green Version]
- Zhou, L.; Kang, D.; Xu, C.; Zhao, W.; Tian, B.; Chen, L. Expression of cyclin D1 and cyclin E significantly associates with human papillomavirus subtypes in Bowenoid papulosis. Acta Histochem. 2013, 115, 339–343. [Google Scholar] [CrossRef]
- Ripple, M.J.; Parker Struckhoff, A.; Trillo-Tinoco, J.; Li, L.; Margolin, D.A.; McGoey, R.; Valle, L.D. Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-Catenin in Colon Cancer. PLoS ONE 2014, 9, e106257. [Google Scholar] [CrossRef]
- Xiang, Z.; Liang, Z.; Yanfeng, H.; Leitao, K. Persistence of RSV promotes proliferation and epithelial-mesenchymal transition of bronchial epithelial cells through Nodal signaling. J. Med. Microbiol. 2017, 66, 1499–1505. [Google Scholar] [CrossRef]
- Xu, Y.; Shi, Y.; Yuan, Q.; Liu, X.; Yan, B.; Chen, L.; Tao, Y.; Cao, Y. Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J. Exp. Clin. Cancer Res. CR 2013, 32, 90. [Google Scholar] [CrossRef]
- Casimiro, M.C.; Velasco-Velázquez, M.; Aguirre-Alvarado, C.; Pestell, R.G. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: Past and present. Expert Opin. Investig. Drugs 2014, 23, 295–304. [Google Scholar] [CrossRef]
- Pestell, R.G. New Roles of Cyclin D1. Am. J. Pathol. 2013, 183, 3–9. [Google Scholar] [CrossRef]
- Klein, E.A.; Assoian, R.K. Transcriptional regulation of the cyclin D1 gene at a glance. J. Cell Sci. 2008, 121, 3853–3857. [Google Scholar] [CrossRef]
- Björndal, A.S.; Szekely, L.; Elgh, F. Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells. BMC Microbiol. 2003, 3, 6. [Google Scholar] [CrossRef]
- Nanbo, A.; Watanabe, S.; Halfmann, P.; Kawaoka, Y. The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Sci. Rep. 2013, 3, srep01206. [Google Scholar] [CrossRef]
- Vecchio, K.D.; Frick, C.T.; Gc, J.B.; Oda, S.; Gerstman, B.S.; Saphire, E.O.; Chapagain, P.P.; Stahelin, R.V. A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine. J. Biol. Chem. 2018, 293, 3335–3349. [Google Scholar] [CrossRef]
- Kota, K.P.; Benko, J.G.; Mudhasani, R.; Retterer, C.; Tran, J.P.; Bavari, S.; Panchal, R.G. High Content Image Based Analysis Identifies Cell Cycle Inhibitors as Regulators of Ebola Virus Infection. Viruses 2012, 4, 1865–1877. [Google Scholar] [CrossRef]
- Wauquier, N.; Becquart, P.; Padilla, C.; Baize, S.; Leroy, E.M. Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis. PLoS Negl. Trop. Dis. 2010, 4, pii: e837. [Google Scholar] [CrossRef]
- Gupta, M.; Spiropoulou, C.; Rollin, P.E. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro. Virology 2007, 364, 45–54. [Google Scholar] [CrossRef]
- Yaddanapudi, K.; Palacios, G.; Towner, J.S.; Chen, I.; Sariol, C.A.; Nichol, S.T.; Lipkin, W.I. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006, 20, 2519–2530. [Google Scholar] [CrossRef]
- Martin, B.; Reynard, O.; Volchkov, V.; Decroly, E. Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding. Antiviral Res. 2018, 150, 183–192. [Google Scholar] [CrossRef]
- Watanabe, S.; Noda, T.; Kawaoka, Y. Functional Mapping of the Nucleoprotein of Ebola Virus. J. Virol. 2006, 80, 3743–3751. [Google Scholar] [CrossRef]
- Huang, Y.; Xu, L.; Sun, Y.; Nabel, G.J. The Assembly of Ebola Virus Nucleocapsid Requires Virion-Associated Proteins 35 and 24 and Posttranslational Modification of Nucleoprotein. Mol. Cell 2002, 10, 307–316. [Google Scholar] [CrossRef]
- Kirchdoerfer, R.N.; Abelson, D.M.; Li, S.; Wood, M.R.; Saphire, E.O. Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex. Cell Rep. 2015, 12, 140–149. [Google Scholar] [CrossRef]
- Bharat, T.A.M.; Noda, T.; Riches, J.D.; Kraehling, V.; Kolesnikova, L.; Becker, S.; Kawaoka, Y.; Briggs, J.A.G. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc. Natl. Acad. Sci. USA 2012, 109, 4275–4280. [Google Scholar] [CrossRef]
- Martin, B.; Canard, B.; Decroly, E. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle. Antiviral Res. 2017, 141, 48–61. [Google Scholar] [CrossRef]
- Dong, S.; Yang, P.; Li, G.; Liu, B.; Wang, W.; Liu, X.; Xia, B.; Yang, C.; Lou, Z.; Guo, Y.; et al. Insight into the Ebola virus nucleocapsid assembly mechanism: Crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolution. Protein Cell 2015, 6, 351–362. [Google Scholar] [CrossRef]
- Dziubańska, P.J.; Derewenda, U.; Ellena, J.F.; Engel, D.A.; Derewenda, Z.S. The structure of the C-terminal domain of the Zaire ebolavirus nucleoprotein. Acta Crystallogr. D Biol. Crystallogr. 2014, 70, 2420–2429. [Google Scholar] [CrossRef]
- Noda, T.; Hagiwara, K.; Sagara, H.; Kawaoka, Y. Characterization of the Ebola virus nucleoprotein–RNA complex. J. Gen. Virol. 2010, 91, 1478–1483. [Google Scholar] [CrossRef]
- Guo, Y.; Wang, W.; Ji, W.; Deng, M.; Sun, Y.; Zhou, H.; Yang, C.; Deng, F.; Wang, H.; Hu, Z.; et al. Crimean–Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc. Natl. Acad. Sci. USA 2012, 109, 5046–5051. [Google Scholar] [CrossRef]
- Hastie, K.M.; Kimberlin, C.R.; Zandonatti, M.A.; MacRae, I.J.; Saphire, E.O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. USA 2011, 108, 2396–2401. [Google Scholar] [CrossRef]
- Qi, X.; Lan, S.; Wang, W.; Schelde, L.M.; Dong, H.; Wallat, G.D.; Ly, H.; Liang, Y.; Dong, C. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 2010, 468, 779–783. [Google Scholar] [CrossRef]
- Hatakeyama, D.; Ohmi, N.; Saitoh, A.; Makiyama, K.; Morioka, M.; Okazaki, H.; Kuzuhara, T. Acetylation of lysine residues in the recombinant nucleoprotein and VP40 matrix protein of Zaire Ebolavirus by eukaryotic histone acetyltransferases. Biochem. Biophys. Res. Commun. 2018, 504, 635–640. [Google Scholar] [CrossRef]
- Fujisawa, T.; Filippakopoulos, P. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. Nat. Rev. Mol. Cell Biol. 2017, 18, 246–262. [Google Scholar] [CrossRef]
- Ren, W.; Wang, C.; Wang, Q.; Zhao, D.; Zhao, K.; Sun, D.; Liu, X.; Han, C.; Hou, J.; Li, X.; et al. Bromodomain protein Brd3 promotes Ifnb1 transcription via enhancing IRF3/p300 complex formation and recruitment to Ifnb1 promoter in macrophages. Sci. Rep. 2017, 7, 39986. [Google Scholar] [CrossRef]
- García-Dorival, I.; Wu, W.; Armstrong, S.D.; Barr, J.N.; Carroll, M.W.; Hewson, R.; Hiscox, J.A. Elucidation of the Cellular Interactome of Ebola Virus Nucleoprotein and Identification of Therapeutic Targets. J. Proteome Res. 2016, 15, 4290–4303. [Google Scholar] [CrossRef]
- Proserpio, V.; Fittipaldi, R.; Ryall, J.G.; Sartorelli, V.; Caretti, G. The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy. Genes Dev. 2013, 27, 1299–1312. [Google Scholar] [CrossRef]
- Ebihara, H.; Takada, A.; Kobasa, D.; Jones, S.; Neumann, G.; Theriault, S.; Bray, M.; Feldmann, H.; Kawaoka, Y. Molecular Determinants of Ebola Virus Virulence in Mice. PLoS Pathog. 2006, 2, e73. [Google Scholar] [CrossRef]
- Hoenen, T.; Shabman, R.S.; Groseth, A.; Herwig, A.; Weber, M.; Schudt, G.; Dolnik, O.; Basler, C.F.; Becker, S.; Feldmann, H. Inclusion Bodies Are a Site of Ebolavirus Replication. J. Virol. 2012, 86, 11779–11788. [Google Scholar] [CrossRef]
- Martin, B.; Hoenen, T.; Canard, B.; Decroly, E. Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry. Antiviral Res. 2016, 135, 1–14. [Google Scholar] [CrossRef]
- Miller, E.H.; Chandran, K. Filovirus entry into cells – new insights. Curr. Opin. Virol. 2012, 2, 206–214. [Google Scholar] [CrossRef]
- Simmons, G. Filovirus Entry. In Viral Entry into Host Cells; Advances in Experimental Medicine and Biology; Springer: New York, NY, USA, 2013; pp. 83–94. ISBN 978-1-4614-7650-4. [Google Scholar]
- Saeed, M.F.; Kolokoltsov, A.A.; Albrecht, T.; Davey, R.A. Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes. PLoS Pathog. 2010, 6, e1001110. [Google Scholar] [CrossRef]
- Nanbo, A.; Imai, M.; Watanabe, S.; Noda, T.; Takahashi, K.; Neumann, G.; Halfmann, P.; Kawaoka, Y. Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner. PLoS Pathog. 2010, 6, e1001121. [Google Scholar] [CrossRef]
- White, J.M.; Schornberg, K.L. A new player in the puzzle of filovirus entry. Nat. Rev. Microbiol. 2012, 10, 317–322. [Google Scholar] [CrossRef]
- Markosyan, R.M.; Miao, C.; Zheng, Y.-M.; Melikyan, G.B.; Liu, S.-L.; Cohen, F.S. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger. PLoS Pathog. 2016, 12, e1005373. [Google Scholar] [CrossRef]
- Volchkov, V.E.; Feldmann, H.; Volchkova, V.A.; Klenk, H.-D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 1998, 95, 5762–5767. [Google Scholar] [CrossRef]
- Jeffers, S.A.; Sanders, D.A.; Sanchez, A. Covalent Modifications of the Ebola Virus Glycoprotein. J. Virol. 2002, 76, 12463–12472. [Google Scholar] [CrossRef]
- Gruenberg, J.; Stenmark, H. The biogenesis of multivesicular endosomes. Nat. Rev. Mol. Cell Biol. 2004, 5, 317–323. [Google Scholar] [CrossRef]
- Gadila, S.K.G.; Kim, K. Cargo trafficking from the trans-Golgi network towards the endosome. Biol. Cell 2016, 108, 205–218. [Google Scholar] [CrossRef]
- Pallesen, J.; Murin, C.D.; de Val, N.; Cottrell, C.A.; Hastie, K.M.; Turner, H.L.; Fusco, M.L.; Flyak, A.I.; Zeitlin, L.; Crowe, J.E., Jr.; et al. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Nat. Microbiol. 2016, 1, 16128. [Google Scholar] [CrossRef]
- Bhattacharyya, S.; Hope, T.J. Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol. J. 2011, 8, 11. [Google Scholar] [CrossRef]
- Escudero-Pérez, B.; Volchkova, V.A.; Dolnik, O.; Lawrence, P.; Volchkov, V.E. Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability. PLoS Pathog. 2014, 10, e1004509. [Google Scholar] [CrossRef]
- Lai, C.-Y.; Strange, D.P.; Wong, T.A.S.; Lehrer, A.T.; Verma, S. Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4. Front. Microbiol. 2017, 8, 1571. [Google Scholar] [CrossRef]
- Okumura, A.; Pitha, P.M.; Yoshimura, A.; Harty, R.N. Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1. J. Virol. 2010, 84, 27–33. [Google Scholar] [CrossRef]
- Iampietro, M.; Santos, R.I.; Lubaki, N.M.; Bukreyev, A. Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation. J. Infect. Dis. 2018, 218, S327–S334. [Google Scholar] [CrossRef]
- Martinez, O.; Johnson, J.C.; Honko, A.; Yen, B.; Shabman, R.S.; Hensley, L.E.; Olinger, G.G.; Basler, C.F. Ebola Virus Exploits a Monocyte Differentiation Program To Promote Its Entry. J. Virol. 2013, 87, 3801–3814. [Google Scholar] [CrossRef]
- Edri, A.; Shemesh, A.; Iraqi, M.; Matalon, O.; Brusilovsky, M.; Hadad, U.; Radinsky, O.; Gershoni-Yahalom, O.; Dye, J.M.; Mandelboim, O.; et al. The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells. Front. Immunol. 2018, 9, 1428. [Google Scholar] [CrossRef]
- Iampietro, M.; Younan, P.; Nishida, A.; Dutta, M.; Lubaki, N.M.; Santos, R.I.; Koup, R.A.; Katze, M.G.; Bukreyev, A. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. PLoS Pathog. 2017, 13, e1006397. [Google Scholar] [CrossRef]
- Maruyama, T.; Parren, P.W.H.I.; Sanchez, A.; Rensink, I.; Rodriguez, L.L.; Khan, A.S.; Peters, C.J.; Burton, D.R. Recombinant Human Monoclonal Antibodies to Ebola Virus. J. Infect. Dis. 1999, 179, S235–S239. [Google Scholar] [CrossRef]
- Mohan, G.S.; Li, W.; Ye, L.; Compans, R.W.; Yang, C. Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus. PLoS Pathog. 2012, 8, e1003065. [Google Scholar] [CrossRef]
- Bixler, S.L.; Goff, A.J. The Role of Cytokines and Chemokines in Filovirus Infection. Viruses 2015, 7, 5489–5507. [Google Scholar] [CrossRef]
- Villinger, F.; Rollin, P.E.; Brar, S.S.; Chikkala, N.F.; Winter, J.; Sundstrom, J.B.; Zaki, S.R.; Swanepoel, R.; Ansari, A.A.; Peters, C.J. Markedly Elevated Levels of Interferon (IFN)-γ, IFN-α, Interleukin (IL)-2, IL-10, and Tumor Necrosis Factor-α Associated with Fatal Ebola Virus Infection. J. Infect. Dis. 1999, 179, S188–S191. [Google Scholar] [CrossRef]
- Baize, S.; Leroy, E.M.; Georges, A.J.; Georges-Courbot, M.C.; Capron, M.; Bedjabaga, I.; Lansoud-Soukate, J.; Mavoungou, E. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 2002, 128, 163–168. [Google Scholar] [CrossRef]
- Trinchieri, G. Interleukin-12 and interferon-gamma. Do they always go together? Am. J. Pathol. 1995, 147, 1534–1538. [Google Scholar]
- Szabo, S.J.; Dighe, A.S.; Gubler, U.; Murphy, K.M. Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 Cells. J. Exp. Med. 1997, 185, 817–824. [Google Scholar] [CrossRef]
- Otani, T.; Nakamura, S.; Toki, M.; Motoda, R.; Kurimoto, M.; Orita, K. Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice. Cell. Immunol. 1999, 198, 111–119. [Google Scholar] [CrossRef]
- Wei, Y.P.; Kita, M.; Shinmura, K.; Yan, X.Q.; Fukuyama, R.; Fushiki, S.; Imanishi, J. Expression of IFN-gamma in cerebrovascular endothelial cells from aged mice. J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. 2000, 20, 403–409. [Google Scholar] [CrossRef]
- Suo, Z.; Tan, J.; Placzek, A.; Crawford, F.; Fang, C.; Mullan, M. Alzheimer’s beta-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40. Brain Res. 1998, 807, 110–117. [Google Scholar] [CrossRef]
- Hakonarson, H.; Maskeri, N.; Carter, C.; Grunstein, M.M. Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 1999, 103, 1077–1087. [Google Scholar] [CrossRef]
- Timoshanko, J.R.; Holdsworth, S.R.; Kitching, A.R.; Tipping, P.G. IFN-γ Production by Intrinsic Renal Cells and Bone Marrow-Derived Cells Is Required for Full Expression of Crescentic Glomerulonephritis in Mice. J. Immunol. 2002, 168, 4135–4141. [Google Scholar] [CrossRef]
- Baize, S.; Leroy, E.M.; Georges-Courbot, M.-C.; Capron, M.; Lansoud-Soukate, J.; Debré, P.; Fisher-Hoch, S.P.; McCormick, J.B.; Georges, A.J. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 1999, 5, 423–426. [Google Scholar] [CrossRef]
- Steel, J.C.; Waldmann, T.A.; Morris, J.C. Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol. Sci. 2012, 33, 35–41. [Google Scholar] [CrossRef]
- Deshmane, S.L.; Kremlev, S.; Amini, S.; Sawaya, B.E. Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. J. Interferon Cytokine Res. 2009, 29, 313–326. [Google Scholar] [CrossRef]
- Kindrachuk, J.; Wahl-Jensen, V.; Safronetz, D.; Trost, B.; Hoenen, T.; Arsenault, R.; Feldmann, F.; Traynor, D.; Postnikova, E.; Kusalik, A.; et al. Ebola Virus Modulates Transforming Growth Factor β Signaling and Cellular Markers of Mesenchyme-Like Transition in Hepatocytes. J. Virol. 2014, 88, 9877–9892. [Google Scholar] [CrossRef]
- Zhang, H.-G.; Liu, C.; Su, K.; Yu, S.; Zhang, L.; Zhang, S.; Wang, J.; Cao, X.; Grizzle, W.; Kimberly, R.P. A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death. J. Immunol. 2006, 176, 7385–7393. [Google Scholar] [CrossRef]
- Chen, T.; Guo, J.; Yang, M.; Zhu, X.; Cao, X. Chemokine-Containing Exosomes Are Released from Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine. J. Immunol. 2011, 186, 2219–2228. [Google Scholar] [CrossRef]
- Zhang, B.; Shen, L.; Shi, H.; Pan, Z.; Wu, L.; Yan, Y.; Zhang, X.; Mao, F.; Qian, H.; Xu, W. Exosomes from Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics. Stem Cells Int. 2016, 2016, 1929536. [Google Scholar] [CrossRef]
- Nickel, W.; Rabouille, C. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 2009, 10, 148–155. [Google Scholar] [CrossRef]
- Konadu, K.A.; Chu, J.; Huang, M.B.; Amancha, P.K.; Armstrong, W.; Powell, M.D.; Villinger, F.; Bond, V.C. Association of Cytokines With Exosomes in the Plasma of HIV-1–Seropositive Individuals. J. Infect. Dis. 2015, 211, 1712–1716. [Google Scholar] [CrossRef]
- Fitzgerald, W.; Freeman, M.L.; Lederman, M.M.; Vasilieva, E.; Romero, R.; Margolis, L. A System of Cytokines Encapsulated in ExtraCellular Vesicles. Sci. Rep. 2018, 8, 8973. [Google Scholar] [CrossRef]
- Smith, J.R.; Todd, S.; Ashander, L.M.; Charitou, T.; Ma, Y.; Yeh, S.; Crozier, I.; Michael, M.Z.; Appukuttan, B.; Williams, K.A.; et al. Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye. Transl. Vis. Sci. Technol. 2017, 6, 12. [Google Scholar] [CrossRef]
- Zeng, X.; Blancett, C.D.; Koistinen, K.A.; Schellhase, C.W.; Bearss, J.J.; Radoshitzky, S.R.; Honnold, S.P.; Chance, T.B.; Warren, T.K.; Froude, J.W.; et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat. Microbiol. 2017, 2, 17113. [Google Scholar] [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pleet, M.L.; DeMarino, C.; Stonier, S.W.; Dye, J.M.; Jacobson, S.; Aman, M.J.; Kashanchi, F. Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Viruses 2019, 11, 410. https://doi.org/10.3390/v11050410
Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman MJ, Kashanchi F. Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Viruses. 2019; 11(5):410. https://doi.org/10.3390/v11050410
Chicago/Turabian StylePleet, Michelle L., Catherine DeMarino, Spencer W. Stonier, John M. Dye, Steven Jacobson, M. Javad Aman, and Fatah Kashanchi. 2019. "Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion" Viruses 11, no. 5: 410. https://doi.org/10.3390/v11050410
APA StylePleet, M. L., DeMarino, C., Stonier, S. W., Dye, J. M., Jacobson, S., Aman, M. J., & Kashanchi, F. (2019). Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Viruses, 11(5), 410. https://doi.org/10.3390/v11050410